Anti-tumor necrosis factor-alpha therapy in severe alcoholic hepatitis: are large randomized trials still possible?

J Hepatol. 2003 Apr;38(4):518-20. doi: 10.1016/s0168-8278(03)00045-x.
No abstract available

Publication types

  • Editorial
  • Review

MeSH terms

  • Antibodies, Monoclonal / administration & dosage*
  • Antibodies, Monoclonal / adverse effects
  • Gastrointestinal Agents / administration & dosage*
  • Gastrointestinal Agents / adverse effects
  • Hepatitis, Alcoholic / drug therapy*
  • Humans
  • Infliximab
  • Randomized Controlled Trials as Topic*
  • Severity of Illness Index
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Antibodies, Monoclonal
  • Gastrointestinal Agents
  • Tumor Necrosis Factor-alpha
  • Infliximab